Jazz Pharmaceuticals (NASDAQ:JAZZ) reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Jazz Pharmaceuticals missed estimated earnings by 6.84%, reporting an EPS of $3.95 versus an estimate of $4.24.
Revenue was up $79.09 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.39 which was followed by a 2.73% increase in the share price the next day.
Here’s a look at Jazz Pharmaceuticals’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.32 | 4.66 | 4.2 | 3.83 |
| EPS Actual | -0.07 | 5.17 | 4.3 | 3.73 |
| Revenue Estimate | 975.59M | 939.06M | 904.21M | 853.52M |
| Revenue Actual | 972.12M | 940.65M | 932.88M | 813.72M |
To track all earnings releases for Jazz Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
